Intrahepatic Cholestasis of Pregnancy
Author Information
Author(s): Pusl Thomas, Beuers Ulrich
Primary Institution: Department of Medicine II, Klinikum Grosshadern, University of Munich, Munich, Germany
Hypothesis
What are the causes and effects of intrahepatic cholestasis of pregnancy (ICP)?
Conclusion
Intrahepatic cholestasis of pregnancy is a condition that can lead to significant risks for both the mother and fetus, but treatment with ursodeoxycholic acid can improve outcomes.
Supporting Evidence
- ICP is observed in 0.4–1% of pregnancies in most areas of Central and Western Europe and North America.
- Treatment with ursodeoxycholic acid significantly improved pruritus and biochemical markers in patients with ICP.
- ICP increases the risk of preterm delivery and other fetal complications, particularly with elevated bile acid levels.
Takeaway
Intrahepatic cholestasis of pregnancy is when pregnant women feel very itchy and have liver problems, but doctors can help with medicine.
Methodology
The study involved randomized controlled trials comparing the effects of ursodeoxycholic acid and other treatments on patients with ICP.
Limitations
The study may not account for all variables affecting outcomes in ICP, and some treatments were not widely accepted due to limited efficacy.
Participant Demographics
The study included symptomatic pregnant women diagnosed with ICP.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website